Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
AKRN Stock Overview
Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral primary and by-products.
Acron Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₽17,868.00 |
52 Week High | ₽29,700.00 |
52 Week Low | ₽5,736.00 |
Beta | -0.50 |
1 Month Change | -0.46% |
3 Month Change | 23.23% |
1 Year Change | 194.37% |
3 Year Change | 290.30% |
5 Year Change | 473.61% |
Change since IPO | 1,727.84% |
Recent News & Updates
Shareholder Returns
AKRN | RU Chemicals | RU Market | |
---|---|---|---|
7D | -4.6% | -2.1% | 2.7% |
1Y | 194.4% | 70.4% | -22.6% |
Return vs Industry: AKRN exceeded the Russian Chemicals industry which returned 70.4% over the past year.
Return vs Market: AKRN exceeded the Russian Market which returned -22.6% over the past year.
Price Volatility
AKRN volatility | |
---|---|
AKRN Average Weekly Movement | 23.1% |
Chemicals Industry Average Movement | 15.3% |
Market Average Movement | 15.5% |
10% most volatile stocks in RU Market | 22.1% |
10% least volatile stocks in RU Market | 9.7% |
Stable Share Price: AKRN is more volatile than 90% of Russian stocks over the past 3 months, typically moving +/- 23% a week.
Volatility Over Time: AKRN's weekly volatility has increased from 11% to 23% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | n/a | Vladimir Kunitsky | https://www.acron.ru |
Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral primary and by-products. The company provides mineral fertilizers, including complex and nitrogen fertilizers; organic compounds comprising methanol, formalin, urea-formaldehyde resins, melamine-urea-formaldehyde resins, and dipping resins; and non-organic compounds, such as low and high density ammonium nitrate, conversion calcium carbonate, liquid carbon dioxide, and urea for diesel exhaust fluid production. It also offers rare earth elements (REE) from apatite concentrate process flows consisting of cerium, lanthanum, neodymium, and didymium, as well as concentrates of light, medium, and heavy REE; and apatite concentrate and ammonia.
Acron Fundamentals Summary
AKRN fundamental statistics | |
---|---|
Market Cap | ₽656.78b |
Earnings (TTM) | ₽58.23b |
Revenue (TTM) | ₽170.99b |
11.3x
P/E Ratio3.8x
P/S RatioIs AKRN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AKRN income statement (TTM) | |
---|---|
Revenue | ₽170.99b |
Cost of Revenue | ₽68.40b |
Gross Profit | ₽102.59b |
Other Expenses | ₽44.36b |
Earnings | ₽58.23b |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 1.58k |
Gross Margin | 60.00% |
Net Profit Margin | 34.06% |
Debt/Equity Ratio | 79.1% |
How did AKRN perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield4%
Payout RatioValuation
Is Acron undervalued compared to its fair value and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
11.28x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: AKRN (RUB17868) is trading above our estimate of fair value (RUB13082.31)
Significantly Below Fair Value: AKRN is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: AKRN is poor value based on its PE Ratio (11.3x) compared to the Russian Chemicals industry average (7.4x).
PE vs Market: AKRN is poor value based on its PE Ratio (11.3x) compared to the Russian market (6.8x).
Price to Earnings Growth Ratio
PEG Ratio: AKRN's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: AKRN is overvalued based on its PB Ratio (7.5x) compared to the RU Chemicals industry average (1.8x).
Future Growth
How is Acron forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score
1/6Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
-16.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AKRN's earnings are forecast to decline over the next 3 years (-16.2% per year).
Earnings vs Market: AKRN's earnings are forecast to decline over the next 3 years (-16.2% per year).
High Growth Earnings: AKRN's earnings are forecast to decline over the next 3 years.
Revenue vs Market: AKRN's revenue is expected to decline over the next 3 years (-0.3% per year).
High Growth Revenue: AKRN's revenue is forecast to decline over the next 3 years (-0.3% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AKRN's Return on Equity is forecast to be high in 3 years time (20%)
Past Performance
How has Acron performed over the past 5 years?
Past Performance Score
4/6Past Performance Score 4/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
8.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AKRN has high quality earnings.
Growing Profit Margin: AKRN became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: AKRN's earnings have grown by 8.9% per year over the past 5 years.
Accelerating Growth: AKRN has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: AKRN has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (53.1%).
Return on Equity
High ROE: AKRN's Return on Equity (51.6%) is considered outstanding.
Financial Health
How is Acron's financial position?
Financial Health Score
4/6Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: AKRN's short term assets (RUB58.8B) exceed its short term liabilities (RUB29.6B).
Long Term Liabilities: AKRN's short term assets (RUB58.8B) do not cover its long term liabilities (RUB97.4B).
Debt to Equity History and Analysis
Debt Level: AKRN's net debt to equity ratio (64.8%) is considered high.
Reducing Debt: AKRN's debt to equity ratio has reduced from 92.3% to 79.1% over the past 5 years.
Debt Coverage: AKRN's debt is well covered by operating cash flow (64.8%).
Interest Coverage: AKRN's interest payments on its debt are well covered by EBIT (22.6x coverage).
Balance Sheet
Dividend
What is Acron current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
0.34%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: AKRN's dividend (0.34%) isn’t notable compared to the bottom 25% of dividend payers in the Russian market (3.8%).
High Dividend: AKRN's dividend (0.34%) is low compared to the top 25% of dividend payers in the Russian market (11.02%).
Stability and Growth of Payments
Stable Dividend: AKRN is not paying a notable dividend for the Russian market, therefore no need to check if payments are stable.
Growing Dividend: AKRN is not paying a notable dividend for the Russian market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: AKRN is not paying a notable dividend for the Russian market.
Cash Payout to Shareholders
Cash Flow Coverage: AKRN is not paying a notable dividend for the Russian market.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
12.1yrs
Average management tenure
CEO
Vladimir Kunitsky (73 yo)
17.33yrs
Tenure
Mr. Vladimir Yakovlevich Kunitsky has been the Chairman of the Managing Board and Chief Executive Officer of Public PJSC Acron (formerly known as Public Joint Stock Company Acron (formerly known as Joint S...
Leadership Team
Experienced Management: AKRN's management team is seasoned and experienced (12.1 years average tenure).
Board Members
Experienced Board: AKRN's board of directors are considered experienced (7 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Public Joint Stock Company Acron's employee growth, exchange listings and data sources
Key Information
- Name: Public Joint Stock Company Acron
- Ticker: AKRN
- Exchange: MISX
- Founded: 1992
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Implied Market Cap: ₽656.777b
- Shares outstanding: 36.76m
- Website: https://www.acron.ru
Location
- Public Joint Stock Company Acron
- World Trade Centre
- 12 Krasnopresnenskaya Naberezhnaya
- Moscow
- Moskovskaya obl.
- 123610
- Russia
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/05/22 00:00 |
End of Day Share Price | 2022/05/20 00:00 |
Earnings | 2021/09/30 |
Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.